Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Yanzhi Guo
East China Normal University (ECNU) - Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
0
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Function-Oriented Synthesis of Imidazo[1,2-a]Pyrazine and Imidazo[1,2-b]Pyridazine Derivatives as Potent PI3K/mTOR Dual Inhibitors
Posted: 08 Nov 2022
Chuchu Li
,
Yuqiao Han
,
Zhengyang Wang
,
Yanan Yu
,
Chen Wang
,
Ziwei Ren
, Yanzhi Guo,
Tong Zhu
,
Xuwen Li
,
Suzhen Dong
and
Mingliang Ma
East China Normal University (ECNU) - Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, East China Normal University (ECNU) - Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, East China Normal University (ECNU) - Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, East China Normal University (ECNU) - Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, Shanghai University of Engineering Science, East China Normal University (ECNU) - Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, East China Normal University (ECNU) - Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, East China Normal University (ECNU) - Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, Chinese Academy of Sciences (CAS) - State Key Laboratory of Drug Research, East China Normal University (ECNU) - Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development and East China Normal University (ECNU) - Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development
Abstract:
PI3K/mTOR dual inhibitors, Cancer, Antitumor activity, Hepatotoxicity.
Feedback
